CME as reported
CME Group reported $6.77B of revenue over the trailing twelve months, +5.1% on the year before. 10 reported series are charted on this page, each one as filed.
$6.77B
Revenue, trailing twelve months · to Q2 2026 · +5.1% against the twelve months before
- Free Cash Flow
- $4.21B
Free Cash Flow · +2.6% year on year · trailing twelve months to Q2 2026
- Op Margin
- 65%
Op Margin · trailing twelve months to Q2 2026
- EPS
- $11.79
EPS · +14% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $6.77B | +5.1% | Q2 2026 |
| Net Income | $3.05B | n/a | Q3 2023 · 11 quarters behind |
| EPS | $11.79 | +14% | Q2 2026 |
| Op Margin | 65% | n/a | Q2 2026 |
| Net Margin | 57% | n/a | Q3 2023 · 11 quarters behind |
| ROE | 11% | n/a | Q3 2023 · 11 quarters behind |
| ROA | 1.9% | n/a | Q3 2023 · 11 quarters behind |
| ROIC | 13% | n/a | Q4 2025 |
| Free Cash Flow | $4.21B | +2.6% | Q2 2026 |
| P/E | 23.8 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
CME Group (CME) - Revenue & ProfitRevenue & ProfitCME Group (CME)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Financial Data & Stock Exchanges
Ranks #3 of 11 by Smart Score